AC
Aarti Chandan Soni
About Aarti Chandan Soni
Data last updated:
Aarti Chandan Soni is a Director at Gripil Pharmaceuticals Private Limited (since 2009) and Director at Gangaveda Private Limited (since 2022). The companies operate in Pharma and Food and Beverages. The largest current company by reported revenue is Gripil Pharmaceuticals Private Limited at ₹5.12 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gripil Pharmaceuticals Private Limited U24100MH2009PTC194336 | Director | 23 Jul 2009 | 2009 | ₹5.12 Cr (FY 2024) | Active |
 Gangaveda Private Limited U15134MH2022PTC383546 | Director | 26 May 2022 | 2022 | Active |
Board colleagues of Aarti Chandan Soni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandan Rajgopal Soni | 02304087 | Gripil Pharmaceuticals Private Limited | Director |
| Mayuri Priyankkumar Savani | 07653293 | Gangaveda Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aarti Chandan Soni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aarti Chandan Soni
Aarti Chandan Soni currently holds 2 directorships: Gripil Pharmaceuticals Private Limited (Director, since 23 Jul 2009, revenue ₹5.12 Cr (FY 2024)); Gangaveda Private Limited (Director, since 26 May 2022).
Aarti Chandan Soni was first appointed on 23 Jul 2009 as Director at Gripil Pharmaceuticals Private Limited. The most recent appointment on record is 26 May 2022 at Gangaveda Private Limited.
The current boards of Aarti Chandan Soni's companies include Chandan Rajgopal Soni (Gripil Pharmaceuticals Private Limited), Mayuri Priyankkumar Savani (Gangaveda Private Limited).